MedEast Bio Completes Hundreds of Millions RMB C++ Financing to Advance Platform Strategy in Healthcare Sector

Recently, MedEast Huicheng Life Sciences (Kunshan) Co., Ltd. (hereinafter referred to as “MedEast Huicheng”) announced the completion of its C++ round financing, amounting to hundreds of millions of yuan, led by Qudao Asset Management. The proceeds from this financing will be utilized for the development and operation of product pipelines in consumer healthcare and life sciences storage solutions.

Founded in Kunshan, Jiangsu Province in 2017, MedEast Huicheng has successfully achieved large-scale commercialization of its CDMO business for minimally invasive surgical devices and is rapidly expanding its operations into the full spectrum of IVD and life sciences. Currently, MedEast Huicheng’s product pipeline has extended into the consumer healthcare sector, poised to ignite a new growth curve.

In terms of surgical instruments, Meidong Huicheng has covered six major series: laparoscopic products, energy-based products, open surgery products, hemostatic products, access products, and colorectal products. Among them,As the core product of Meidong Huicheng, surgical ancillary components rank among the top in China in terms of both R&D and manufacturing capabilities.

In the life sciences sector, Meidong Huicheng has established automated liquid handling workstations as its entry point, gradually expanding its portfolio to include manual pipettes, centrifuges, and other instruments. Furthermore, Meidong Huicheng offers a comprehensive range of life science consumables, meeting the needs of experimental procedures such as liquid handling, PCR, nucleic acid extraction, centrifugation, cryopreservation, and cell culture.Meidong Huicheng is among the first enterprises in China to integrate the R&D, production, and sales of laboratory equipment, reagents, and consumables.

In November 2024, Meidong Huicheng globally launched the first semi-automatic intelligent liquid nitrogen storage system. Featuring liquid nitrogen refrigeration, a standard automated hoisting arm, and a series of other innovative designs, this system addresses pain points associated with traditional storage equipment, such as labor-intensive operation, susceptibility to errors, low efficiency, and risks of cold shock injury. It also effectively mitigates issues related to power constraints while promoting energy conservation and environmental protection. By enhancing the convenience and accuracy of sample access, the system offers user-friendly and efficient performance comparable to fully automatic storage solutions, thereby reducing storage costs.Meidong Huicheng is also the first equipment manufacturer in China’s industry to propose achieving stable storage at -86°C and -196°C through liquid nitrogen refrigeration.

In the consumer healthcare sector, the GEEK portable oxygen concentrator, exclusively developed by Meidong Huicheng, boasts advantages such as compact size, portability, the use of high-altitude cyanobacteria compressors, and extended operational time, thereby filling the long-standing gap in China’s third-generation portable oxygen concentrators.

As a high-tech enterprise, Meidong Huicheng is committed to building a “smart manufacturing” platform for consumables in the fields of minimally invasive surgery and life sciences. The company has accumulated a series of corporate honors, including “Jiangsu Province Potential Unicorn Enterprise,” “Jiangsu Province Private Science and Technology Enterprise,” “Suzhou Unicorn Cultivation Enterprise,” and “National High-Tech Enterprise.” Meanwhile, targeting domestic market demand under the broader context of “import substitution,” Meidong Huicheng is also actively participating in the formulation of new national industry standards, leading industry development.

Technical innovation stems from a professional team. Meidong Huicheng boasts a multidisciplinary team united by shared philosophies and a common vision, comprising experts from renowned international biotechnology corporations, specialized R&D and design teams in minimally invasive surgery, and top-tier engineers in the manufacturing sector. Currently, the company’s workforce exceeds 850 employees, remaining committed to technology-driven product innovation, meticulous craftsmanship, and delivering on trust.

Meidong Huicheng provides comprehensive services to medical device enterprises, including product research and development, design, manufacturing, and final assembly. Its downstream clients currently cover 80% of domestic medical device manufacturers in China, and it has established deep strategic partnerships with leading industry players such as Sino Biological, WuXi AppTec, and Tianchen Medical.

Lead Investor in This Round: Qudao AssetsStatement: As a long-standing shareholder of Meidong Huicheng and the lead investor in its Series C++ financing round, we remain firmly confident in the company’s growth potential. Its robust mass-production capabilities combined with a craftsman’s spirit constitute the core significance and competitive advantages of its positioning as a major intelligent manufacturing platform for healthcare. Spanning from CDMO services for minimally invasive surgical instruments to life science tools and further to the oxygen concentrator segment within consumer healthcare, the company has demonstrated a clear development strategy, excellent product selection capabilities, and exceptional execution. Notably, in the field of next-generation portable oxygen concentrators, the company has broken the monopoly held by imported technologies and achieved domestic substitution for high-end portable models, delivering outstanding performance in regions with harsh environments and critical demand, such as high-altitude areas. The investment proceeds from this fund will be used to establish production facilities for the company’s next-generation portable oxygen concentrator business in the Ganjiang New Area of Jiangxi Province, which is expected to drive further development of the new area’s big health industry and foster industrial synergy.